StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
8052.KL$0.89-0.56%
Fair $0.89+0.0%

8052.KL

Central Global Berhad

Basic Materials / Specialty ChemicalsKuala Lumpur

$0.89

-0.00 (-0.56%)

Fairly Valued+0.0%Fair Value $0.89Fund rank 26/100 · Data gapFallback financials|
SA 26/D
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 21%

FCF escenarios

weak_data · normalized FCF $-39.4M · quality 57.7/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 25/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

26/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is 1.5%, below the 5% threshold
Thesis & Journal · 8052.KLLocal privado en este navegador · Central Global Berhad
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$745M

P/E

N/A

•

EV/EBITDA

114.4x

↑

ROE

1.5%

↑

Gross Margin

13.4%

↓

Debt/Equity

0.70

↑
52-Week Range$1
$1$1

TradingView lightweight chart

8052.KL price, volumen y niveles de valoración

Último $0.890Periodo -75.0%
Fair value: $0.890

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2021–2024 · 3 años de histórico normalizado

Revenue CAGR

+9.1%

FCF CAGR

—

FCF margin

-32.4%

FCF / Net income

-30.55x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $139.0M · net income $1.5M · FCF $-45.1M

2021-FY → 2024-FY

Gross margin

13.4%+7.8% pts

Operating margin

2.4%+8.5% pts

Net margin

1.1%+7.7% pts

FCF margin

-32.4%-15.5% pts
MetricTTM
2024
2023
2022
2021
Income Statement
Revenue$139.0M$139.0M$218.6M$211.2M$107.1M
Net Income$1.5M$1.5M$-42.1M$7.5M$-7.1M
EBITDA$6.5M$6.5M$-30.1M$18.8M$-4.7M
EPS——-0.070.02-0.02
Gross Margin13.4%13.4%12.1%16.4%5.5%
Operating Margin2.4%2.4%-14.7%9.2%-6.1%
Net Margin1.1%1.1%-19.2%3.5%-6.6%
Balance Sheet
Debt/Equity0.700.700.420.120.24
Current Ratio1.551.55———
Cash Flow
Free Cash Flow$-45.1M$-45.1M$-39.4M$-13.2M$-18.1M
Returns
ROE1.5%1.5%-48.9%8.1%-14.6%
Valuation
P/E———59.74—
EV/EBITDA114.37114.37—23.93—
P/B6.866.8623.274.858.31
Growth & Yield
Revenue Growth-36.4%-36.4%3.5%97.3%—
EPS Growth——-530.5%181.8%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +0.0%

Total return

+0.0%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.07 → n/d

Residual

+0.0%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+0.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.